Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Pfizer
Istanbul Training and Research Hospital
Regeneron Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Alliance for Clinical Trials in Oncology
Jonsson Comprehensive Cancer Center
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Novartis